The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 19.30

All Lymphoid Neoplasms With Detailed Non-Hodgkin Lymphoma Subtypesa

SEERb 5-Year Relative Survival (Percent) by Age at Diagnosis
All Races, Males, 2007-2013

Site All Ages Ages 0-19 Ages 20-64 Ages 65+
Count Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval
Low High Low High Low High Low High
Lymphoid Neoplasm 99,036 69.6 69.2 70.0 89.9 89.0 90.8 76.0 75.6 76.5 59.1 58.4 59.8
1 Hodgkin Lymphoma 8,117 85.6 84.6 86.5 96.3 94.6 97.4 88.8 87.8 89.7 56.6 52.2 60.6
2 Non-Hodgkin lymphoma 88,734 68.6 68.2 69.0 88.4 87.3 89.4 74.6 74.1 75.1 59.7 59.0 60.4
2(a) Non-Hodgkin lymphoma, B-cell 81,691 69.0 68.5 69.4 89.1 87.9 90.2 75.5 75.0 76.0 60.3 59.5 61.1
2(a) 1. Precursor Non-Hodgkin lymphoma, B-cell 4,401 68.3 66.7 69.8 88.3 86.8 89.6 38.4 35.2 41.6 17.4 12.5 23.0
2(a) 2. Mature Non-Hodgkin lymphoma, B-cell 73,377 69.2 68.7 69.7 92.0 89.6 93.9 76.9 76.4 77.5 60.7 59.9 61.5
2(a) 2.1. Chronic/Small/Prolymphocytic/ Mantle B-cell Non-Hodgkin lymphoma 19,315 78.2 77.3 79.2 - - - 86.3 85.2 87.3 71.8 70.3 73.2
2(a) 2.1.1. Chronic/Small lymphocytic leukemia/lymphoma 16,568 81.7 80.6 82.6 - - - 89.4 88.2 90.4 75.6 74.0 77.1
2(a) 2.1.2. Prolymphocytic leukemia, B-cell 63 52.9 35.5 67.6 - - - 70.1 44.5 85.6 40.8 20.3 60.3
2(a) 2.1.3. Mantle-cell lymphoma 2,684 57.3 54.7 59.9 - - - 68.7 65.2 71.9 46.9 42.9 50.8
2(a) 2.2. Lymphoplasmacytic lymphoma/ Waldenstrom macroglubulinemia 1,680 80.6 77.0 83.6 - - - 87.6 83.3 90.9 76.2 71.0 80.6
2(a) 2.2.1. Lymphoplasmacytic lymphoma 732 77.5 72.0 82.1 - - - 82.3 75.1 87.7 74.5 66.5 80.9
2(a) 2.2.2. Waldenstrom macroglubulinemia 948 83.0 78.1 86.9 - - - 91.4 85.4 95.0 77.6 70.3 83.2
2(a) 2.3. Diffuse large B-cell lymphoma (DLBCL) 18,768 62.3 61.4 63.2 91.2 86.8 94.2 69.9 68.8 70.9 52.5 50.9 54.0
2(a) 2.3.1. DLBCL, NOSc 18,562 62.3 61.3 63.2 91.3 86.8 94.3 69.9 68.9 71.0 52.5 51.0 54.1
2(a) 2.3.2. Intravascular large B-cell lymphoma 28 35.8 15.7 56.5 - - - - - - - - -
2(a) 2.3.3. Primary effusion lymphoma 47 22.2 9.1 38.8 - - - 18.4 6.2 35.7 - - -
2(a) 2.3.4. Mediastinal large B-cell lymphoma 131 83.8 73.3 90.4 - - - 85.1 73.9 91.8 - - -
2(a) 2.4. Burkitt lymphoma/leukemia 1,607 64.3 61.6 66.9 91.2 87.5 93.8 59.1 55.7 62.3 41.5 32.9 49.9
2(a) 2.5. Marginal-zone lymphoma (MZL) 4,449 89.1 87.2 90.7 100.0 - - 92.2 90.3 93.7 85.4 81.9 88.3
2(a) 2.5.1. Splenic MZL 386 85.4 78.0 90.5 - - - 81.2 72.1 87.6 85.9 77.0 91.6
2(a) 2.5.2. Extranodal MZL, MALTc type 2,649 94.0 91.6 95.7 100.0 - - 95.3 93.0 96.8 92.2 86.9 95.5
2(a) 2.5.3. Nodal MZL 1,414 80.6 76.9 83.8 - - - 88.2 84.2 91.2 73.5 67.5 78.6
2(a) 2.6. Follicular lymphoma 8,827 87.0 85.8 88.1 96.7 77.2 99.6 90.8 89.6 91.8 80.9 78.5 83.2
2(a) 2.7. Hairy-cell leukemia 1,252 93.9 91.0 95.9 - - - 96.4 93.6 97.9 86.4 78.3 91.6
2(a) 2.8. Plasma cell neoplasms 17,461 49.5 48.5 50.6 - - - 61.2 59.8 62.6 39.5 38.0 40.9
2(a) 2.8.1. Plasmacytoma 1,199 68.5 64.6 72.0 - - - 77.0 72.6 80.7 55.6 48.3 62.3
2(a) 2.8.2. Multiple myeloma/ plasma-cell leukemia 16,262 48.1 47.0 49.2 - - - 59.7 58.2 61.1 38.6 37.1 40.1
2(a) 2.9. Heavy chain disease - - - - - - - - - - - - -
2(a) 3. Non-Hodgkin lymphoma, B-cell, NOSc 3,913 66.2 63.9 68.3 92.9 81.8 97.3 73.5 70.7 76.0 59.8 56.3 63.1
2(b) Non-Hodgkin lymphoma, T-cell 6,454 64.4 62.9 65.8 86.6 83.9 88.8 66.5 64.7 68.3 50.0 46.7 53.1
2(b) 1. Precursor Non-Hodgkin lymphoma, T-cell 282 66.4 60.4 71.7 88.6 82.0 92.9 47.2 37.9 56.0 - - -
2(b) 2. Mature Non-Hodgkin lymphoma, T-cell 6,151 64.3 62.7 65.8 86.0 83.0 88.6 67.3 65.4 69.1 50.6 47.3 53.8
2(b) 2.1. Mycosis fungoides/Sezary syndrome 1,472 88.3 85.2 90.8 100.0 - - 90.8 87.8 93.1 81.6 73.4 87.5
2(b) 2.1.1. Mycosis fungoides 1,422 90.1 87.0 92.5 100.0 - - 91.9 88.9 94.1 85.1 76.4 90.7
2(b) 2.1.2. Sezary syndrome 50 31.8 13.4 51.9 - - - - - - 26.8 5.3 55.5
2(b) 2.2. Peripheral T-cell lymphoma 3,330 56.1 54.0 58.2 82.9 75.7 88.2 62.8 60.2 65.3 42.4 38.6 46.2
2(b) 2.2.1. Peripheral T-cell lymphoma, NOSc 1,195 38.9 35.5 42.4 63.8 41.9 79.3 47.3 42.7 51.7 26.5 21.4 31.9
2(b) 2.2.2. Angioimmunoblastic T-cell lymphoma 411 35.8 30.1 41.6 - - - 43.4 34.9 51.5 29.2 21.3 37.5
2(b) 2.2.3. Subcutaneous panniculitis- like T-cell lymphoma 30 87.0 60.2 96.3 - - - - - - - - -
2(b) 2.2.4. Anaplastic large cell lymphoma, T-cell or null-cell type 686 59.9 55.5 64.1 88.2 79.7 93.3 63.5 58.1 68.4 34.2 24.6 44.0
2(b) 2.2.5. Hepatosplenic T-cell lymphoma 38 21.8 7.8 40.4 - - - 21.9 5.6 45.0 - - -
2(b) 2.2.6. Enteropathy-type T-cell lymphoma 32 12.6 3.2 28.7 - - - - - - - - -
2(b) 2.2.7. Cutaneous T-cell lymphoma, NOSc 649 83.6 78.9 87.4 - - - 86.9 81.9 90.7 76.6 67.7 83.3
2(b) 2.2.8. Primary cutaneous anaplastic large cell lymphoma 289 88.0 80.6 92.7 - - - 93.8 86.6 97.2 78.2 60.3 88.7
2(b) 2.3. Adult T-cell leukemia/lymphoma 930 66.9 63.2 70.3 86.2 82.5 89.2 48.7 42.2 54.8 9.2 1.1 28.6
2(b) 2.4. NKc/T-cell lymphoma, nasal-type/ agressive NKc-cell leukemia 296 42.9 36.2 49.4 - - - 42.0 34.3 49.4 38.1 23.6 52.5
2(b) 2.5. T-cell large granular lymphocytic leukemia 31 62.8 40.2 78.9 - - - - - - - - -
2(b) 2.6. Prolymphocytic leukemia, T-cell 92 17.9 8.5 30.1 - - - 19.6 8.3 34.3 14.5 2.9 35.0
2(b) 3. Non-Hodgkin lymphoma, NOSc , T-cell - - - - - - - - - - - - -
2(c) Non-Hodgkin lymphoma, unknown lineage 589 56.1 51.5 60.5 83.3 75.7 88.8 53.4 46.5 59.8 40.6 32.2 48.7
2(c) 1. Precursor lymphoblastic leukemia/ lymphoma, unknown lineage 249 60.5 53.8 66.5 82.9 75.2 88.5 38.4 26.5 50.1 25.0 11.9 40.5
2(c) 2. Prolymphocytic leukemia, unknown lineage - - - - - - - - - - - - -
2(c) 3. Non-Hodgkin lymphoma, NOSc, unknown lineage 321 53.0 46.5 59.1 - - - 59.7 51.3 67.1 44.1 34.0 53.7
2(*) 1. Total precursor lymphoma/leukemiad 4,932 67.9 66.4 69.3 88.1 86.7 89.4 39.5 36.6 42.4 17.9 13.3 23.0
3 Composite Hodgkin lymphoma and Non-Hodgkin lymphoma 85 78.9 65.2 87.6 - - - 81.3 68.0 89.5 - - -
4 Lymphoid neoplasm, NOSc 2,100 48.8 46.0 51.4 84.7 72.2 91.9 58.6 54.9 62.2 38.6 34.6 42.6

Footnotes:

a Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.

b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).

c NOS = Not otherwise specified. MALT = Mucosa-associated lymphoid tissue. NK = Natural killer.

- Statistic not displayed due to less than 25 cases.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.